Two cases of disseminated tuberculosis after negative screening before adalimumab treatment for immune-mediated inflammatory diseases

Rita Fernanda Cortez de Almeida; Ricardo Cortez Cardoso Penha; Lívia do Nascimento Barbosa

doi:10.1016/j.jdcr.2019.09.008

Two cases of disseminated tuberculosis after negative screening before adalimumab treatment for immune-mediated inflammatory diseases

JAAD Case Rep. 2019 Oct 31;5(11):1002-1005. doi: 10.1016/j.jdcr.2019.09.008. eCollection 2019 Nov.

Authors

Rita Fernanda Cortez de Almeida¹, Ricardo Cortez Cardoso Penha², Lívia do Nascimento Barbosa¹

Affiliations

¹ Dermatology Department, Federal Hospital of Bonsucesso, Rio de Janeiro, Brazil.
² Molecular Carcinogenesis Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

No abstract available

Keywords: CT, computed tomography; HS, hidradenitis suppurativa; IGRA, interferon-γ release assay; IL, interleukin; RIPE, rifampicin, isoniazid, pyrazinamide, and ethambutol; TB, tuberculosis; TNF, tumor necrosis factor; TST, tuberculin skin test; adalimumab; anergy; hidradenitis suppurativa; inflammatory immune-mediated diseases; psoriasis; tuberculosis.

Publication types

Case Reports